Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England

• Main Authors: Kilcoyne A (Author), Jordan E (Author), Thomas K (Author), Pepper AN (Author), Zhou A (Author), Chappell D (Author), Amarapala M (Author), Thériault RK (Author), Thompson M (Author)
• Format: Book
• Published: Dove Medical Press, 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Adrian Kilcoyne,1 Edward Jordan,1 Kimberly Thomas,2 Alicia N Pepper,2 Allen Zhou,2 Dale Chappell,1 Miyuru Amarapala,1 Rachel-Karson Thériault,2 Melissa Thompson2 1HEOR, Humanigen Inc, Burlingame, CA, USA; 2Value & Evidence Services, EVERSANA, Burlington, Ontario, CanadaCorrespondence: Adrian Kil...